调节NFκB和PI3K的动态增强了集体级TNFR1信号介导的亡反应
Shubhank Sherekar1, Chaitra S Todankar1, Ganesh A Viswanathan2
1Department of Chemical Engineering, Indian Institute of Technology Bombay Powai, Mumbai, 400076, India.
NPJ systems biology and applications
|November 17, 2023
概括
瘤坏死因子受体1 (TNFR1) 信号显示了细胞的可变性. 调节信号流,特别是Comp1-IKK*活动,可以引导癌细胞进入细胞亡,从而增强治疗策略.
科学领域:
- 细胞信号传输的动态
- 系统生物学 系统生物学
- 癌症细胞命运的决定
背景情况:
- 瘤坏死因子受体1 (TNFR1) 信号表现出细胞对细胞的变异性,导致不同的亲生存和亡结果.
- 细胞内信号异质性决定了细胞存活和死亡表型之间的平衡.
研究的目的:
- 研究TNFR1信号通路的调节,以促进单细胞中细胞亡.
- 开发和应用一种计算方法来预测细胞表型可达性.
主要方法:
- 对TNFR1信号网络的系统布尔动态建模.
- 开发"基于布尔模拟的现型可达性稳定状态概率预测 (BM-ProSPR) "以进行高效的现型预测.
- 模型分析与实验观测的对比.
主要成果:
- 信号流路径的变化可以调节以促进细胞亡.
- NFκB和PI3K的短暂反应动态调节XIAP,协调亲生存和亡途径.
- 阻止Comp1-IKK*活动通过重新连接信号流向细胞亡而增加了约31%的细胞亡,而不会影响NFκB水平.
结论:
- 针对Comp1-IKK*相互作用提供了一种在癌细胞中诱导亡的策略.
- 像BM-ProSPR这样的计算建模对于理解和预测复杂的细胞信号行为是有价值的.
- 调节细胞内信号动态为癌症治疗提供了一个有前途的途径.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


